NIH-funded research R01 grant

How urolithin A may help reverse heart aging

Official title: Mechanisms underlying reversal of cardiac aging by urolithin a treatment

Funded at University of Washington · NIH-10877344 · Data updated 2026-11-12

This study is looking at how a compound called urolithin A might help improve heart health and function as we get older, especially for older adults who may be facing heart-related issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 15, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$647,672
NIH project number1R01AG081395-01A1
Project IDNIH-10877344 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who are experiencing age-related cardiovascular decline.

Less likely to help

Patients with pre-existing severe cardiovascular conditions or those under 21 years old may not benefit from this research.

What this research studies

This research investigates the effects of urolithin A on reversing the aging process in the heart. It focuses on understanding how this compound can improve mitochondrial function, which is crucial for maintaining healthy heart performance as we age. The study will involve assessing cardiac function and cellular dynamics in older adults to determine if urolithin A can mitigate age-related cardiovascular issues. Patients may be monitored for changes in heart muscle cells and overall cardiovascular health.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve heart health and reduce the risk of cardiovascular diseases in older adults.

How similar studies have gone: Previous research has shown promising results with mitochondrial-targeted therapies in improving heart function in aging populations.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Marcinek, David J. — University of Washington
  • Study coordinator: Marcinek, David J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.